May 28, 2020 / 08:30PM GMT
Operator
Good afternoon, and welcome to the Adverum Biotechnologies First Quarter 2020 Corporate Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to hand the call over to Myesha Lacy, Vice President of Investor Relations and Corporate Communications of Adverum. Please go ahead.
Myesha Lacy - Adverum Biotechnologies, Inc. - VP of IR & Corporate Communications
Thank you, and welcome, everyone. Today, we issued a press release announcing our new INFINITY trial for ADVM-022 and diabetic macular edema as well as reporting our financial results for the first quarter of 2020. A copy can be found on the Press Releases page of the Investor Relations section of our corporate website at www.adverum.com. Also posted on our IR website is a slide presentation to accompany this call, which is available on the Events and Presentation page of the IR section of our website. Also, a replay of today's call will also be available.
Q1 2020 Adverum Biotechnologies Inc Earnings Call Transcript
May 29, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers